Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 80

Comparing sodium levels in dialysis for ICU patients with kidney injury

Official title: Effects of Variation of Sodium Dialysate in ICU Acute Kiney Injury

Run by University Hospital, Montpellier · NCT03329313 · Data updated 2026-11-12

This study is testing if using a lower sodium level in dialysis can help ICU patients with kidney injury feel more stable and avoid extra fluid buildup.

More Acute Kidney Injury trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment158 (estimated)
SponsorUniversity Hospital, Montpellier
Academic / other
Locations1 site (Montpellier, Montpellier)
StatusRecruiting
StartedApril 19, 2018
Main results expectedDecember 19, 2026
Study endsDecember 19, 2026
Registry record updatedSeptember 30, 2025
Trial IDNCT03329313 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with acute kidney injury requiring renal replacement therapy and a SOFA score greater than 5.

Probably not a fit

Patients with chronic kidney disease stage IV or V, obstructive acute kidney injury, or those who are moribund with a high risk of death within 48 hours may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of different sodium concentrations in dialysate on hemodynamic tolerance and fluid overload in ICU patients suffering from acute kidney injury (AKI) requiring renal replacement therapy. The study compares two groups of patients receiving sustained low efficiency daily dialysis-filtration (SLEDD-f) with dialysate sodium concentrations of 140 mmol/l and 145 mmol/l. The goal is to determine if a lower sodium concentration can maintain hemodynamic stability while reducing the risk of fluid overload, which is associated with higher mortality in critically ill patients. Participants will be monitored over a 7-day period to assess their response to the different sodium levels.

Why it matters

Potential benefit: If successful, this study could lead to improved dialysis protocols that enhance patient safety and outcomes in critically ill patients with AKI.

How similar studies have gone: Previous studies have indicated that varying dialysate sodium concentrations can impact hemodynamic tolerance, suggesting that this approach may yield beneficial results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age \> 18 years old
* Acute kidney injury requiring renal replacement therapy
* Dialysis type: on line sustained low efficiency dialy dialysis -filtration
* SOFA score \> 5
* Sodium serum level between 135 and 145mmol/l

Exclusion criteria:

* Chronic kidney disease stade IV ou V
* Obstrutive acute kidney injury
* Renal tansplantation in the year before ICU admission
* Moribund with risk of death in the 48 hours
* Vulnerable persons or protected persons
* Pregnant or breastfeeding mother

Where it's running

  • Uhmontpellier
    Montpellier, Montpellier, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.